Canada markets closed

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
6.85+0.18 (+2.70%)
At close: 04:00PM EDT
6.89 +0.04 (+0.57%)
After hours: 07:20PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
1,053
81
1,030
1,144
0
Operating Expenses
Research Development
21,218
38,670
23,135
18,031
16,085
Selling General and Administrative
10,696
13,331
11,999
8,077
6,308
Total Operating Expenses
31,914
52,001
35,134
26,108
22,393
Operating Income or Loss
-30,861
-51,920
-34,104
-24,964
-22,393
Income Before Tax
-30,380
-48,818
-33,017
-24,774
-22,215
Income from Continuing Operations
-30,380
-48,818
-33,017
-24,774
-22,215
Net Income
-30,380
-48,818
-33,017
-24,774
-22,215
Net Income available to common shareholders
-30,380
-48,818
-33,017
-24,774
-22,216
Basic EPS
-1.93
-1.83
-1.37
-1.20
-1.83
Diluted EPS
-1.93
-1.83
-1.37
-1.20
-1.83
Basic Average Shares
26,120
26,604
24,142
20,568
12,134
Diluted Average Shares
26,120
26,604
24,142
20,568
12,134